as of 03-02-2026 3:30pm EST
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | SAN CLEMENTE |
| Market Cap: | 3.9B | IPO Year: | 1995 |
| Target Price: | $182.25 | AVG Volume (30 days): | 272.9K |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.03 | EPS Growth: | 100.62 |
| 52 Week Low/High: | $107.02 - $160.29 | Next Earning Date: | 05-22-2026 |
| Revenue: | $2,231,262,000 | Revenue Growth: | -6.33% |
| Revenue Growth (this year): | -1.54% | Revenue Growth (next year): | 4.10% |
| P/E Ratio: | 4973.67 | Index: | N/A |
| Free Cash Flow: | 91.8M | FCF Growth: | -26.36% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
ICUI Breaking Stock News: Dive into ICUI Ticker-Specific Updates for Smart Investing
See how ICUI stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "ICUI ICU Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.